Adaptmet: Deconstructing adaptive evolution of metastasis
Adaptmet aims to develop an advanced training program encompassing the multifaceted aspects of metastasis adaptation mechanisms, intending t...
2024-07-05 - 2029-02-28 | Financiado
2024-07-05 - 2029-02-28 | Financiado
DEFINITIVE: Diagnostic HER2DX-guided treatment for patients with early-stage HER2-positive breast cancer
GR ESPANOL DE ESTUDIO Y TRATAMIENTODE INTENSIFIC. Y OTRAS ESTRATEG.EXPERIMENT. EN TUMORES SOLIDOS - GRUPO SOLTI
participó en un
HORIZON EUROPE:
HORIZON-MISS-2023-CANCER-01
HER2+ breast cancer affects around 390.000 women annually worldwide (i.e. 3 patients every 4 minutes). Over the last decade, polychemotherap...
2023-12-11 - 2028-11-30 | Financiado
2023-12-11 - 2028-11-30 | Financiado
* No se disponen de datos de la empresa actual.